BioSpace News Archive

Almirall, S.A. (ALM) the global biopharmaceutical company based in Barcelona, has announced its 9M 2020 financial results.

SynAct Pharma AB announced that an independent Data Safety Monitoring Board has reviewed unblinded and validated data from part 1 of the company’s Phase 2a study in patients with rheumatoid arthritis with high disease activity with the aim to recommend which dose of AP1189 to be brought into part 2 of the study.

International medical imaging IT and cybersecurity company Sectra [STO: SECT B] has deployed its software for medical imaging at Leeds Teaching Hospitals.

Interim analysis from HPTN 084 study shows long-acting injectable cabotegravir administered every two months is 89% more effective than daily pills in preventing HIV acquisition in women

MercachemSyncom, the leading mid-sized European drug-discovery contract research organization, announced that it has acquired Admescope Ltd. based in Oulu, Finland and Södertälje, Sweden.

TaiGen Biotechnology Company, Limited announced that they have signed an exclusive agreement with GPCR Therapeutics, Inc., a leading Korean biotechnology company, for the continued development of Burixafor worldwide and the commercialization of Taigexyn® in South Korea.

Brain Canada announces the 2019 Azrieli Future Leaders in Canadian Brain Research grant recipients

Introducing a new portfolio of heart valve products aiming to restore health and extend life

GeoMx Digital Spatial Profiler (DSP) Now Enables Multi-Analyte Spatial Analysis Using Both NGS and nCounter Read-outs

Indicating a substantial recovery from the impact of COVID-19, Total Net Revenue (“Revenue”) was $291.8 million in the third quarter of 2020, a sequential increase of 53.1% from the second quarter of 2020 and a decrease of only 0.3% from last year’s third quarter of $292.7 million As a result of aggressive cost containment measures, Adjusted EBITDA (1) was $45.8 million in the third quarter of 2020, a sequential increase of 102.8% from the second quarter of 2020 and an increase of 11.7% fr